TGFB1 and cancer: Suppression of ELK3 through epigenetic activation of GATA3 rendered cancer cells unresponsive to TGF-β and led to their reprogramming into a non-invasive, cuboidal-like, epithelial state, as observed both in vitro and in vivo [109].